How does personal-importation discretion work in Australia?

The lane and the lead time matter as much as the material for what I am doing.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What is the correct interpretation, and what is the common misreading?

"For research use only" is a statement by the seller about intended use, and it binds nobody.

Onward supply — including at cost, including to friends — is treated separately and much more seriously in most regimes than importation for personal use.

Mechanically, if the amount at stake is material, this is a question for a lawyer in your jurisdiction rather than for a forum in any jurisdiction.

Research-use-only labelling is a commercial convention originating in laboratory supply and carries no regulatory status for an individual importer.

Prior successful deliveries tell you about enforcement, not about legality.

Answer first: the legal position depends entirely on your jurisdiction, and the honest answer to a general question is that you need the local rule rather than a general one.

Most agents discussed on this site are prescription-only medicines where they are licensed at all, which places personal importation under medicines regulation rather than under drug-control law in most jurisdictions.

In practice, the authority that matters is the national medicines regulator plus the customs authority, and both usually publish their position in plain language on their own websites.

The caveat is the whole answer: nothing here is legal advice and the rule that applies to you is local.

Personal importation and onward supply are different acts under different rules.

Start with the classification of the specific substance where you live, because the answer differs by substance and not only by country.

Enforcement posture and legal position are not the same thing. Consignments arriving without incident establish nothing about the underlying rule.

National medicines regulators and customs authorities publish their positions directly, and those are the primary sources for any specific question.

Research-use labelling is a seller's statement, not a legal category for you.

Mechanically, the relevant distinction is between substances that are scheduled, substances that are prescription-only medicines and substances that are unclassified.

Some jurisdictions provide a limited personal-importation allowance for medicines, usually bounded by quantity, by a supply period and by a requirement that the substance is for the importer's own use. Others provide none.

Absence of enforcement is not permission, and prior deliveries prove nothing about the rule.

Look up your own regulator and customs authority. They publish the answer directly.

edited 6 Sept 2024 by ines_brandt — corrected a unit error in the worked example